| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal homeostasis of pH and Zinc: The prelude for cerebral Aβ amyloid formation?
|
Bush, A.I.
|
|
1996
|
6 |
Supplement 3 |
p. 20-
1 p.
|
artikel
|
| 2 |
Activity of 5HT-3 receptor active compounds in animal behavioural models of anxiety
|
Sedman, G.
|
|
1996
|
6 |
Supplement 3 |
p. 116-
1 p.
|
artikel
|
| 3 |
Activity of noradrenegic locus coeruleus (LC) neurons in monkey during performance of an attentional task
|
Aston-Jones, G.
|
|
1996
|
6 |
Supplement 3 |
p. 167-
1 p.
|
artikel
|
| 4 |
Adenosine A2A agonists: A potential, new type of atypical antipsychotics
|
Ögren, S.O.
|
|
1996
|
6 |
Supplement 3 |
p. S4-21-S4-22
NaN p.
|
artikel
|
| 5 |
Age of onset in primary affective disorders: Epidemiological and genetic studies
|
Ravindran, L
|
|
1996
|
6 |
Supplement 3 |
p. 251-
1 p.
|
artikel
|
| 6 |
Alcoholism and liver enzymes
|
Marković, P.
|
|
1996
|
6 |
Supplement 3 |
p. 1-
1 p.
|
artikel
|
| 7 |
Amisulpride in the treatment of acute episodes of schizophrenia
|
Puech, A.J.
|
|
1996
|
6 |
Supplement 3 |
p. 61-
1 p.
|
artikel
|
| 8 |
Ammonium acetate challenge in experimental chronic hepatic encephalopathy induces a transient increase of brain 5-HT release in vivo
|
Bergqvist, Peter B.F.
|
|
1996
|
6 |
Supplement 3 |
p. 317-322
6 p.
|
artikel
|
| 9 |
A new method to quantify effects of benzodiazepines on normal daily activities: Ambulatory accelerometry in psychopharmacological research
|
Tulen, J.H.M.
|
|
1996
|
6 |
Supplement 3 |
p. S4-142-
1 p.
|
artikel
|
| 10 |
Animal models for neuroaids
|
Bloom, F.E.
|
|
1996
|
6 |
Supplement 3 |
p. 22-
1 p.
|
artikel
|
| 11 |
Antidepressant effects of tianeptine, of its two enantiomers and its predominant metabolite in the learned helplessness test in rats
|
Lacroix, P.
|
|
1996
|
6 |
Supplement 3 |
p. S4-70-
1 p.
|
artikel
|
| 12 |
Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist in the forced swimming test in rats
|
Dereń-Wesołek, A.
|
|
1996
|
6 |
Supplement 3 |
p. S4-74-
1 p.
|
artikel
|
| 13 |
Anxiolytic effects of Y-23684 in normal humans with high- and low-anxiety
|
Mizuki, Y.
|
|
1996
|
6 |
Supplement 3 |
p. 115-
1 p.
|
artikel
|
| 14 |
Apparent lack of regulation of muscarinic receptors on rat brain synaptosomes
|
Geurts, M.
|
|
1996
|
6 |
Supplement 3 |
p. 191-
1 p.
|
artikel
|
| 15 |
Are drug-placebo differences in the treatment ofanxiety disorders shrinking over the years?
|
Rickels, K.
|
|
1996
|
6 |
Supplement 3 |
p. 154-
1 p.
|
artikel
|
| 16 |
A review of the nosological status and aetiological theories of postpartum psychosis
|
George, T.
|
|
1996
|
6 |
Supplement 3 |
p. 14-
1 p.
|
artikel
|
| 17 |
Association of neurotrophin-3 gene variant with severe forms of schizophrenia
|
Nanko, S.
|
|
1996
|
6 |
Supplement 3 |
p. 174-
1 p.
|
artikel
|
| 18 |
Atypical neuroleptics in older monkeys
|
Casey, Daniel E.
|
|
1996
|
6 |
Supplement 3 |
p. 28-
1 p.
|
artikel
|
| 19 |
Behavioural and biochemical effects of dopamine D3 antisense administration
|
Ekman, A.
|
|
1996
|
6 |
Supplement 3 |
p. 140-141
2 p.
|
artikel
|
| 20 |
Beyond averaging: Extracting physiological ERP sub-processes from conventional ERP data
|
Gordon, E.
|
|
1996
|
6 |
Supplement 3 |
p. 215-
1 p.
|
artikel
|
| 21 |
Brain corticosteroid receptors and stress system disorders
|
de Kloet, E.R.
|
|
1996
|
6 |
Supplement 3 |
p. 83-
1 p.
|
artikel
|
| 22 |
Brain neurotoxic lesions in rats: Study of the neuroprotective effects of CDP-Choline
|
Miguel-Hidalgo, J.J.
|
|
1996
|
6 |
Supplement 3 |
p. 193-194
2 p.
|
artikel
|
| 23 |
Cell membrane components in the thalamus of schizophrenic brains
|
Gottfries, C.G.
|
|
1996
|
6 |
Supplement 3 |
p. 212-
1 p.
|
artikel
|
| 24 |
Childhood predictors of schizotypal features in non-psychotic adults
|
Cornblatt, B.
|
|
1996
|
6 |
Supplement 3 |
p. 99-
1 p.
|
artikel
|
| 25 |
Chronic treatment with eltoprazine does not lead to tolerance in its anti-aggressive action, in contrast to haloperidol
|
Mos, Jan
|
|
1996
|
6 |
Supplement 3 |
p. 1-7
7 p.
|
artikel
|
| 26 |
Cigarette smoking and mood: The psychological processes which underlie nicotine addiction
|
Parrott, A.C.
|
|
1996
|
6 |
Supplement 3 |
p. 2-3
2 p.
|
artikel
|
| 27 |
Circadian variation in the ambulatory and drinking activities after repeated administration of cocaine in rats
|
Asami, T.
|
|
1996
|
6 |
Supplement 3 |
p. 103-
1 p.
|
artikel
|
| 28 |
Clinical differences in response to mianserin and fluoxetine in depressive patients
|
Lavergne, F.
|
|
1996
|
6 |
Supplement 3 |
p. 125-126
2 p.
|
artikel
|
| 29 |
Clinical profile of mirtazapine
|
van Moffaert, M.
|
|
1996
|
6 |
Supplement 3 |
p. S4-63-S4-64
NaN p.
|
artikel
|
| 30 |
Clinical relevence of antibodies against serotonin and gangliosides, and acute phase proteins in major depression
|
Sluzewska, A.
|
|
1996
|
6 |
Supplement 3 |
p. S4-75-
1 p.
|
artikel
|
| 31 |
Clinico-pharmacokinetic prognosis of prophylactic efficacy of carbamazepine, oxcarbazepine and sodium valproate in affective and schizoaffective disorders
|
Kouzavkova, M.
|
|
1996
|
6 |
Supplement 3 |
p. S4-90-
1 p.
|
artikel
|
| 32 |
Co-administration of paroxetine and haloperidol in chronic schizophrenia
|
Lee, M.S.
|
|
1996
|
6 |
Supplement 3 |
p. 147-
1 p.
|
artikel
|
| 33 |
Cognitive performance and mood changes over 24 hours of smoking abstinence
|
Parrott, A.C.
|
|
1996
|
6 |
Supplement 3 |
p. 119-
1 p.
|
artikel
|
| 34 |
Comparison between self-evaluation and observer-reported scales in a sample of dysthymic patients
|
Janiri, L.
|
|
1996
|
6 |
Supplement 3 |
p. 210-
1 p.
|
artikel
|
| 35 |
Complex presentations of bipolar disorder
|
Himmelhoch, J.
|
|
1996
|
6 |
Supplement 3 |
p. 219-
1 p.
|
artikel
|
| 36 |
Continuous infusion of haloperidol and delerium in intensive care unit
|
Aït-ameur, A.
|
|
1996
|
6 |
Supplement 3 |
p. 133-
1 p.
|
artikel
|
| 37 |
CP-154,526: A potent and selective non-peptide CRF receptor antagonist
|
Schulz, D.
|
|
1996
|
6 |
Supplement 3 |
p. 218-
1 p.
|
artikel
|
| 38 |
CYP2D6 drug interaction potential of four SSRI's using in vivo dextromethorphan
|
Ereshefsky, L.
|
|
1996
|
6 |
Supplement 3 |
p. 3-
1 p.
|
artikel
|
| 39 |
Cytochrome P-450 isozymes and N-demethylation of citalopram enantiomers in vitro: Clinical significance?
|
Rochat, B.
|
|
1996
|
6 |
Supplement 3 |
p. 42-
1 p.
|
artikel
|
| 40 |
Depression as a spreading neuronal adjustment disorder
|
Harro, Jaanus
|
|
1996
|
6 |
Supplement 3 |
p. 207-223
17 p.
|
artikel
|
| 41 |
Distribution of dopamine receptor subtypes in the post-mortem human brain
|
Hall, H.
|
|
1996
|
6 |
Supplement 3 |
p. 157-
1 p.
|
artikel
|
| 42 |
Does severe depression have a different pharmacology?
|
Aschauer, H.N.
|
|
1996
|
6 |
Supplement 3 |
p. S4-3-S4-4
NaN p.
|
artikel
|
| 43 |
D-serine: A putative endogenous modulator of the NMDA receptor
|
Nishikawa, T.
|
|
1996
|
6 |
Supplement 3 |
p. 228-
1 p.
|
artikel
|
| 44 |
Economic impact of improved work performance after treatment of chronic depression
|
Russell, J.M.
|
|
1996
|
6 |
Supplement 3 |
p. 128-
1 p.
|
artikel
|
| 45 |
Effect of gender, age and smoking on doses and plasma levels of neuroleptics in schizophrenia
|
Salokangas, R.K.R.
|
|
1996
|
6 |
Supplement 3 |
p. 36-
1 p.
|
artikel
|
| 46 |
Effect of idebenone on in vivo serotonin release and serotonergic receptors in young and aged rats
|
Scavini, C.
|
|
1996
|
6 |
Supplement 3 |
p. 95-102
8 p.
|
artikel
|
| 47 |
Effects of anapsos on brain histamine and IL-1β levels in an animal model of neurodegeneration
|
Franco-Maside, A.
|
|
1996
|
6 |
Supplement 3 |
p. 193-
1 p.
|
artikel
|
| 48 |
Effects of chronic administration of fluvoxamine on extracellular levels of serotonin in the rat hippocampus in vivo
|
Tajima, O.
|
|
1996
|
6 |
Supplement 3 |
p. 50-51
2 p.
|
artikel
|
| 49 |
Effects of clozapine on sleep-EEG measures in schizophrenia
|
Tandon, Rajiv
|
|
1996
|
6 |
Supplement 3 |
p. 221-
1 p.
|
artikel
|
| 50 |
Effects of lithium and carbamazepine on serum calcium concentrations in neuropsychiatric patients
|
Shinkai, T.
|
|
1996
|
6 |
Supplement 3 |
p. 185-
1 p.
|
artikel
|
| 51 |
Effects of the SSRIS on cognitive function
|
Oxman, T.
|
|
1996
|
6 |
Supplement 3 |
p. 121-122
2 p.
|
artikel
|
| 52 |
Effects of verapamil and ethaverine on the behavioral despair test in rats
|
Kim, Y.H.
|
|
1996
|
6 |
Supplement 3 |
p. 54-
1 p.
|
artikel
|
| 53 |
Endorphins and experimental drug addiction
|
Gerrits, M.A.F.M.
|
|
1996
|
6 |
Supplement 3 |
p. S4-5-S4-6
NaN p.
|
artikel
|
| 54 |
Extrapyramidal symptoma and tolerability of olanzapine versus haloperidol in acute treatment
|
Dellva, M.A.
|
|
1996
|
6 |
Supplement 3 |
p. S4-106-
1 p.
|
artikel
|
| 55 |
Eye movements made during the performance of a maze test in Schizophrenic patients
|
Ando, H.
|
|
1996
|
6 |
Supplement 3 |
p. 64-
1 p.
|
artikel
|
| 56 |
Fluoxetine plus naltrexone in the treatment of bulimia nervosa
|
Bandecchi, Alessandro
|
|
1996
|
6 |
Supplement 3 |
p. 224-
1 p.
|
artikel
|
| 57 |
Fluvoxamine for children and adolescents with Obsessive Compulsive Disorder: A controlled multicenter trial
|
Riddle, Mark A.
|
|
1996
|
6 |
Supplement 3 |
p. S4-144-S4-145
NaN p.
|
artikel
|
| 58 |
GABA mechanisms in sleep deprivation and their relevance to depression
|
Holsboer-Trachsler, E.
|
|
1996
|
6 |
Supplement 3 |
p. 32-
1 p.
|
artikel
|
| 59 |
Genes and the mechanism of action of ECT: Focus on 5-HT1A receptors
|
Segman, R.
|
|
1996
|
6 |
Supplement 3 |
p. 20-
1 p.
|
artikel
|
| 60 |
Glutamate and No in cell signalling
|
Beart, P.M.
|
|
1996
|
6 |
Supplement 3 |
p. 225-
1 p.
|
artikel
|
| 61 |
Glycine/NMDA antagonists reduce amphetamine disruptions in prepulse inhibition in the rat
|
Bristow, L.J.
|
|
1996
|
6 |
Supplement 3 |
p. 44-
1 p.
|
artikel
|
| 62 |
Growth hormone-releasing peptide stimulates growth hormone, ACTH and cortisol secretion and sleep in man
|
Steiger, A.
|
|
1996
|
6 |
Supplement 3 |
p. 176-
1 p.
|
artikel
|
| 63 |
High temporal resolution functional brain electrical activity mapping in attention deficit hyperactive disorder (ADHD)
|
Farrow, M.A.
|
|
1996
|
6 |
Supplement 3 |
p. 203-
1 p.
|
artikel
|
| 64 |
Hippocampal volume reduction and cognitive deficits: Course from high risk to chronic schizophrenia
|
Velahoulis, D.
|
|
1996
|
6 |
Supplement 3 |
p. 100-
1 p.
|
artikel
|
| 65 |
Histamine mediates long-term potentiation of excitability in rat hippocampus
|
Selbach, O.
|
|
1996
|
6 |
Supplement 3 |
p. S4-162-S4-163
NaN p.
|
artikel
|
| 66 |
5-HT6 and 5-HT7 receptors: New targets for neuropsychiatry
|
Sleight, A.J.
|
|
1996
|
6 |
Supplement 3 |
p. S4-42-S4-43
NaN p.
|
artikel
|
| 67 |
5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats
|
Moreau, J.-L.
|
|
1996
|
6 |
Supplement 3 |
p. 169-175
7 p.
|
artikel
|
| 68 |
Immunosuppressive effect of neuroleptic drugs — is it integrated in their antipsychotic action?
|
Leykin, I.
|
|
1996
|
6 |
Supplement 3 |
p. S4-113-
1 p.
|
artikel
|
| 69 |
Induction of c-fos gene expression by the selective sigma receptor ligand EMD 57445 in rat brain
|
Dahmen, Norbert
|
|
1996
|
6 |
Supplement 3 |
p. 237-243
7 p.
|
artikel
|
| 70 |
Intact 5-HT2A receptor gene in schizophrenia
|
Ohara, K.
|
|
1996
|
6 |
Supplement 3 |
p. 173-
1 p.
|
artikel
|
| 71 |
Interactions between ifenprodil and dizocilpine on mouse behaviour in models of anxiety and working memory
|
Fraser, C.M.
|
|
1996
|
6 |
Supplement 3 |
p. 311-316
6 p.
|
artikel
|
| 72 |
Interrater reliability and the PANSS — What does it tell us about efficacy in neuroleptic trials?
|
Lambert, T.J.R.
|
|
1996
|
6 |
Supplement 3 |
p. 199-200
2 p.
|
artikel
|
| 73 |
Intracerebroventricular (icv) administration of CCK-antisense oligodeoxynucleotides prevent anxiety-behavior in rats
|
Cohen, H.
|
|
1996
|
6 |
Supplement 3 |
p. S4-153-S4-154
NaN p.
|
artikel
|
| 74 |
In vivo examination of the Pre- and postsynaptic dopamine neurons in huntington's disease
|
Ginovart, N.
|
|
1996
|
6 |
Supplement 3 |
p. 130-
1 p.
|
artikel
|
| 75 |
Is paroxetine in post-stroke depression useful?
|
Rutigliano, G.
|
|
1996
|
6 |
Supplement 3 |
p. 7-
1 p.
|
artikel
|
| 76 |
Ketamine: Neurophysiological study of subanesthetic doses in patients with chronic pain
|
Oga, K.
|
|
1996
|
6 |
Supplement 3 |
p. 134-
1 p.
|
artikel
|
| 77 |
L-3 Actions of drugs used against mood disorders on second messenger systems: A focus on the cAMP signaling system
|
Mørk, A.
|
|
1996
|
6 |
Supplement 3 |
p. S1-S2
2 p.
|
artikel
|
| 78 |
Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis
|
Emilien, Gérard
|
|
1996
|
6 |
Supplement 3 |
p. 245-252
8 p.
|
artikel
|
| 79 |
Lithium therapy: Some considerations about safety
|
Rutigliano, G.
|
|
1996
|
6 |
Supplement 3 |
p. 10-11
2 p.
|
artikel
|
| 80 |
Long-term effects of alprazolam on memory: A 3 1/2 year follow up of agoraphobic patients
|
Kiliç, C.
|
|
1996
|
6 |
Supplement 3 |
p. S4-141-
1 p.
|
artikel
|
| 81 |
Long-term impact of stressors and affective episodes on vulnerability to recurrence and cycling
|
Post, R.M.
|
|
1996
|
6 |
Supplement 3 |
p. 151-
1 p.
|
artikel
|
| 82 |
Low kinetic interaction potential of flesinoxan in man
|
Van Harten, J.
|
|
1996
|
6 |
Supplement 3 |
p. 39-
1 p.
|
artikel
|
| 83 |
L-9 Psychoimmunological aspects of mood disorders
|
Ackenheil, M.
|
|
1996
|
6 |
Supplement 3 |
p. S6-
1 p.
|
artikel
|
| 84 |
Managed care and antidepressant pharmacotherapy: Economic considerations
|
Robinson, L.M.
|
|
1996
|
6 |
Supplement 3 |
p. S4-54-
1 p.
|
artikel
|
| 85 |
Mechanistic studies with addictive sedative-hypnotics and related drugs in the mouse
|
Shulman, A.
|
|
1996
|
6 |
Supplement 3 |
p. 118-
1 p.
|
artikel
|
| 86 |
Memory-enhancing effects of benzodiazepines in mice
|
Voigt, J.-P.
|
|
1996
|
6 |
Supplement 3 |
p. 253-255
3 p.
|
artikel
|
| 87 |
Mirtazapine lacks typical SSRI-related adverse effects
|
Rekers, R.
|
|
1996
|
6 |
Supplement 3 |
p. 47-
1 p.
|
artikel
|
| 88 |
Naloxone reveals decreased threshold for hypothalamic CRH release in PTSD
|
Jackson, R.
|
|
1996
|
6 |
Supplement 3 |
p. 80-
1 p.
|
artikel
|
| 89 |
Nefazodone vs. Sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction
|
Shrivastava, R.K.
|
|
1996
|
6 |
Supplement 3 |
p. 48-
1 p.
|
artikel
|
| 90 |
Neurophysiological effects of drugs of abuse on dopamine neurons in vitro during development
|
Mereu, G.
|
|
1996
|
6 |
Supplement 3 |
p. 29-
1 p.
|
artikel
|
| 91 |
Neuroprotective effects of the pyrrolopyrimidine U-104067F against 3-acetylpyridin neurotoxicity
|
Sethy, V.
|
|
1996
|
6 |
Supplement 3 |
p. 194-
1 p.
|
artikel
|
| 92 |
Neurotherapeutic potential of 5-HT3 receptor antagonists
|
Palfreyman, M.G.
|
|
1996
|
6 |
Supplement 3 |
p. S4-41-S4-42
NaN p.
|
artikel
|
| 93 |
Neurotransmitter modulation of coupling in locus coeruleus
|
Osborne, P.B.
|
|
1996
|
6 |
Supplement 3 |
p. 168-
1 p.
|
artikel
|
| 94 |
Neurotrophic factors: Biology & clinical potential
|
Lindsay, R.M.
|
|
1996
|
6 |
Supplement 3 |
p. 96-
1 p.
|
artikel
|
| 95 |
New anticonvulsive compounds of sulfonamide derivatives line
|
Zlenko, H.
|
|
1996
|
6 |
Supplement 3 |
p. 186-
1 p.
|
artikel
|
| 96 |
NGF plasma levels in psychiatric patients treated with ECT: Results at IV and VIII ECT
|
Bersani, G.
|
|
1996
|
6 |
Supplement 3 |
p. 182-
1 p.
|
artikel
|
| 97 |
Nicotine dependence in schizophrenia: Basic mechanisms
|
Svensson, T.H.
|
|
1996
|
6 |
Supplement 3 |
p. 231-
1 p.
|
artikel
|
| 98 |
Nightmares: Their relationships with mental disorders and sleep disorders
|
Ohayon, M.M.
|
|
1996
|
6 |
Supplement 3 |
p. 136-137
2 p.
|
artikel
|
| 99 |
Nocturnal plasma melatonin levels after flunitrazepam administration in healthy subjects
|
Hajak, Göran
|
|
1996
|
6 |
Supplement 3 |
p. 149-153
5 p.
|
artikel
|
| 100 |
No evidence of association between dopamine D3 receptor gene and bipolar disorder in a sardinian sample
|
Severino, C.
|
|
1996
|
6 |
Supplement 3 |
p. S4-112-
1 p.
|
artikel
|
| 101 |
Novel substituted acyl-prolyl dipeptide, GVS-111, diminishes cognitive impairment on the model of ischemic stroke in rats
|
Romanova, G.A.
|
|
1996
|
6 |
Supplement 3 |
p. S4-100-
1 p.
|
artikel
|
| 102 |
Olanzapine in the treatment of schizoaffective disorder
|
Lu, Y.
|
|
1996
|
6 |
Supplement 3 |
p. S4-106-
1 p.
|
artikel
|
| 103 |
On the possible role of testosterone in serotonin-related psychiatric disorders in Women
|
Eriksson, E.
|
|
1996
|
6 |
Supplement 3 |
p. 13-
1 p.
|
artikel
|
| 104 |
P-7 Affective disorders are accompanied by cerebral asymmetry changes
|
Egorov, Alexel Y.
|
|
1996
|
6 |
Supplement 3 |
p. S13-
1 p.
|
artikel
|
| 105 |
P-41 Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors
|
Przegaliński, E.
|
|
1996
|
6 |
Supplement 3 |
p. S24-
1 p.
|
artikel
|
| 106 |
P-10 Blunted thyroid stimulating hormone and unaltered growth hormone responses to thyrothropine releasing hormone in major depression
|
Eryllmaz, M.M.
|
|
1996
|
6 |
Supplement 3 |
p. S14-
1 p.
|
artikel
|
| 107 |
Personality disorders are disorders of the personality
|
López-Ibor Jr., J.J.
|
|
1996
|
6 |
Supplement 3 |
p. S4-1-S4-2
NaN p.
|
artikel
|
| 108 |
Petstudies of D1 and D2 dopamine receptors in schizophrenic patients
|
Okubo, Y.
|
|
1996
|
6 |
Supplement 3 |
p. 73-
1 p.
|
artikel
|
| 109 |
Pharmaco EEG effects of S(+) DN-2327 enantiomer and DN-2327 racemate
|
Dietrich, B.
|
|
1996
|
6 |
Supplement 3 |
p. 179-
1 p.
|
artikel
|
| 110 |
Pharmacological profile of benzodiazepine site ligands with recombinant GABAA receptor subtypes
|
Graham, David
|
|
1996
|
6 |
Supplement 3 |
p. 119-125
7 p.
|
artikel
|
| 111 |
Pharmacology and the relevance for choice
|
Preskorn, S.H.
|
|
1996
|
6 |
Supplement 3 |
p. S4-63-
1 p.
|
artikel
|
| 112 |
Pharmacology of ‘Seroquel’ (ICI 204,636): An atypical dibenzothiazepine antipsychotic
|
Goldstein, J.M.
|
|
1996
|
6 |
Supplement 3 |
p. 107-
1 p.
|
artikel
|
| 113 |
Phencyclidine (PCP) alters excitability in CA1 hippocampal neurons by inhibiting local circuit inhibition and increasing transmembraneous calcium influx
|
Grunze, H.
|
|
1996
|
6 |
Supplement 3 |
p. S4-101-
1 p.
|
artikel
|
| 114 |
Plasma neuroleptic level and clinical effects of nemonapride-factors weakening the correlation
|
Fujimaki, H.
|
|
1996
|
6 |
Supplement 3 |
p. 4-
1 p.
|
artikel
|
| 115 |
P-24 Milnacipran: A double and well-balanced noradrenaline and serotonin reuptake inhibitor: Results of comparative clinical trials
|
Tournoux, A.
|
|
1996
|
6 |
Supplement 3 |
p. S18-
1 p.
|
artikel
|
| 116 |
Potentials of MAO-A and B inhibitors in the clinic
|
Youdim, M.B.H.
|
|
1996
|
6 |
Supplement 3 |
p. 164-
1 p.
|
artikel
|
| 117 |
P-3 Pramipexole, a selective dopamine receptor agonist with potential antidepressant activity
|
Maj, J.
|
|
1996
|
6 |
Supplement 3 |
p. S11-S12
2 p.
|
artikel
|
| 118 |
Prodromes of schizophrenia
|
Maurer, K.
|
|
1996
|
6 |
Supplement 3 |
p. S4-59-S4-60
NaN p.
|
artikel
|
| 119 |
Prolyl-leucyl-glycinamide, thyrotropin releasing hormone and β-endorphin-(10–16), like antidepressants, inhibit the effects of melatonin on rat behaviour
|
Wolterink, G.
|
|
1996
|
6 |
Supplement 3 |
p. S4-86-S4-87
NaN p.
|
artikel
|
| 120 |
Psychosocial interventions in schizophrenia: Partnership into the 21st century
|
Tarrier, Nicholas
|
|
1996
|
6 |
Supplement 3 |
p. 25-
1 p.
|
artikel
|
| 121 |
Psychotropic comedication and adverse event rates. Results from a fluoxetine drug surveillance study
|
Dittmann, R.W.
|
|
1996
|
6 |
Supplement 3 |
p. 125-
1 p.
|
artikel
|
| 122 |
P-58 The analgesic effect of amlodipine and its interaction with morphine, ketorolac and naloxone after peripheral and central administration in mice
|
Dogrul, A.
|
|
1996
|
6 |
Supplement 3 |
p. S30-
1 p.
|
artikel
|
| 123 |
P-55 The effects of amlodipine and verapamil after peripheral and central administration against pentylenetetrazole convulsions
|
Dogrul, A.
|
|
1996
|
6 |
Supplement 3 |
p. S29-
1 p.
|
artikel
|
| 124 |
Rapid onset of antidepressant action in an animal model of depression
|
Papp, M.
|
|
1996
|
6 |
Supplement 3 |
p. S4-22-
1 p.
|
artikel
|
| 125 |
Reduction of the positive symptoms of schizophrenia by ‘Seroquel’ (ICI 204,636): Results from phase II and III clinical trials
|
Hong, W.W.
|
|
1996
|
6 |
Supplement 3 |
p. S4-125-
1 p.
|
artikel
|
| 126 |
Refractory depression: First line treatment
|
Beckmann, H.
|
|
1996
|
6 |
Supplement 3 |
p. 93-
1 p.
|
artikel
|
| 127 |
Relationship between akathisia and parkinsonism in schizophrenic patients who receive neuroleptics
|
Brunner, E.
|
|
1996
|
6 |
Supplement 3 |
p. 171-
1 p.
|
artikel
|
| 128 |
Reversible metabolism of clozapine and clozapine N-oxide
|
Chang, W.H.
|
|
1996
|
6 |
Supplement 3 |
p. 39-
1 p.
|
artikel
|
| 129 |
Role of G-protein in the control of neurotensin receptor internalization
|
Hermans, E.
|
|
1996
|
6 |
Supplement 3 |
p. 196-197
2 p.
|
artikel
|
| 130 |
Safety profile of flesinoxan; results form a meta-analysis of studies in patients with major depressive disorder or generalised anxiety disorder
|
de Voogd, J.M.
|
|
1996
|
6 |
Supplement 3 |
p. S4-143-S4-144
NaN p.
|
artikel
|
| 131 |
Salivary cortisol response to psychological stress in healthy adults and children: Comparison of two different stimuli
|
Jansan, L.M.C.
|
|
1996
|
6 |
Supplement 3 |
p. S4-164-
1 p.
|
artikel
|
| 132 |
Scopolamine is a model of memory dysfunction, not of aging
|
Riedel, W.
|
|
1996
|
6 |
Supplement 3 |
p. 144-
1 p.
|
artikel
|
| 133 |
Sensitization to psychostimulants depends upon glutamate transmission in the nucleus accumbens
|
Kalivas, P.W.
|
|
1996
|
6 |
Supplement 3 |
p. 160-161
2 p.
|
artikel
|
| 134 |
Serotonin-induced platelet calcium response in eating disorders
|
Okamoto, Y.
|
|
1996
|
6 |
Supplement 3 |
p. 57-
1 p.
|
artikel
|
| 135 |
Serotonin metabolism and 5-HT1A receptors in genetically defined fear-induced aggression
|
Popova, N.K.
|
|
1996
|
6 |
Supplement 3 |
p. 77-
1 p.
|
artikel
|
| 136 |
Sertraline did not affect monoamine receptors and adenylate cyclase activity in rat brain
|
Tadokoro, C.
|
|
1996
|
6 |
Supplement 3 |
p. 54-
1 p.
|
artikel
|
| 137 |
Sertraline in obsessive-compulsive spectrum disorders — A case study series
|
Bisserbe, J.C.
|
|
1996
|
6 |
Supplement 3 |
p. 112-
1 p.
|
artikel
|
| 138 |
Smoked or I.V. Cocaine binges in humans: Is there a “crash”?
|
Foltin, R.W.
|
|
1996
|
6 |
Supplement 3 |
p. 68-
1 p.
|
artikel
|
| 139 |
Social phobia: What is it and who has it?
|
Stein, M.B.
|
|
1996
|
6 |
Supplement 3 |
p. 150-
1 p.
|
artikel
|
| 140 |
Stimulant-induced behavioral sensitization and gene expression in developing rats
|
Kajii, Y.
|
|
1996
|
6 |
Supplement 3 |
p. 161-
1 p.
|
artikel
|
| 141 |
Stress and depression: A hypothesis on their biological interface
|
van Praag, H.M.
|
|
1996
|
6 |
Supplement 3 |
p. S4-34-S4-35
NaN p.
|
artikel
|
| 142 |
Switching from a conventional antipsychotic (haloperidol) to an atypical antipsychotic (‘Seroquel’ ’ ICI 204,636)
|
Hellewell, J.S.E.
|
|
1996
|
6 |
Supplement 3 |
p. S4-123-
1 p.
|
artikel
|
| 143 |
The assessment of PTSD in veterans
|
Raphael, B.
|
|
1996
|
6 |
Supplement 3 |
p. 80-
1 p.
|
artikel
|
| 144 |
The concept of vigilance and aspects of thymoleptic effects in depressive disorder
|
Herrmann, W.M.
|
|
1996
|
6 |
Supplement 3 |
p. 210-
1 p.
|
artikel
|
| 145 |
The effects of clozapine and remoxipride on Latent Inhibition in rats
|
Trimble, K.M.
|
|
1996
|
6 |
Supplement 3 |
p. 106-
1 p.
|
artikel
|
| 146 |
The effects of moclobemide on sexual desire and function in healthy volunteers
|
Kennedy, Sidney H.
|
|
1996
|
6 |
Supplement 3 |
p. 177-181
5 p.
|
artikel
|
| 147 |
The effects of neuroleptics in rats with neonatal hippocampal damage; A search for more effective treatment of schizophrenia
|
Lipska, B.K.
|
|
1996
|
6 |
Supplement 3 |
p. S4-44-S4-45
NaN p.
|
artikel
|
| 148 |
The effects of rilmenidine on memory, attention and planning in the elderly
|
Mander, A.G.
|
|
1996
|
6 |
Supplement 3 |
p. 144-
1 p.
|
artikel
|
| 149 |
The 5-HT1A receptor antagonist WAY-100635 enhances the behavioural effects of SSRIs
|
Dourish, C.T.
|
|
1996
|
6 |
Supplement 3 |
p. 16-17
2 p.
|
artikel
|
| 150 |
The level of glutamine synthetase in Alzheimer's disease brain
|
Burbaeva, G.
|
|
1996
|
6 |
Supplement 3 |
p. 188-
1 p.
|
artikel
|
| 151 |
The long-term efficacy and safety of paroxetine in panic disorder
|
Judge, R.
|
|
1996
|
6 |
Supplement 3 |
p. 207-
1 p.
|
artikel
|
| 152 |
The neuropathology of schizophrenia: Autoradiographic and in situ hybridization studies
|
Kleinman, J.E.
|
|
1996
|
6 |
Supplement 3 |
p. 92-93
2 p.
|
artikel
|
| 153 |
The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder
|
van Megen, Harold J.G.M.
|
|
1996
|
6 |
Supplement 3 |
p. 187-194
8 p.
|
artikel
|
| 154 |
The paroxetine challenge test for in vivo evaluation of serotonin function in man
|
Reist, C.
|
|
1996
|
6 |
Supplement 3 |
p. 176-
1 p.
|
artikel
|
| 155 |
The peculiarities of the meperedine action in early ontogenesis
|
Zlenko, H.
|
|
1996
|
6 |
Supplement 3 |
p. 109-
1 p.
|
artikel
|
| 156 |
The presynaptic release apparatus: A main site in the mechanism of action of psychotropic drugs
|
Popoli, M.
|
|
1996
|
6 |
Supplement 3 |
p. S4-81-
1 p.
|
artikel
|
| 157 |
The role of in vivo amygdala dopamine to cocaine self-administration behavior
|
Hurd, Y.L.
|
|
1996
|
6 |
Supplement 3 |
p. 67-
1 p.
|
artikel
|
| 158 |
Time course for dopamine and serotonin receptor occupancy in the brain of schizophrenic patients following dosing with 150 mg ‘seroquel’ TID
|
Gefvert, O.
|
|
1996
|
6 |
Supplement 3 |
p. 74-
1 p.
|
artikel
|
| 159 |
Trazodone versus clonidine in rapid detoxification from opiates
|
Conte, G.L.
|
|
1996
|
6 |
Supplement 3 |
p. S4-134-S4-135
NaN p.
|
artikel
|
| 160 |
Treatment maintenance time in panic disorder with or without agoraphobia
|
Corominas, A.
|
|
1996
|
6 |
Supplement 3 |
p. S4-140-
1 p.
|
artikel
|
| 161 |
Treatment outcome in poor metabolizers versus extensive metabolizers in a population of psychotic patients in Denmark and Norway
|
Bjarking, L.
|
|
1996
|
6 |
Supplement 3 |
p. S4-153-
1 p.
|
artikel
|
| 162 |
Twenty years of clinical experience with the use of clozapine in severe psychotic patients
|
Ciprian-Ollivier, J.
|
|
1996
|
6 |
Supplement 3 |
p. 200-
1 p.
|
artikel
|
| 163 |
Use of citalopram, a serotonin selective reuptake inhibitor, in OCD
|
Stein, D.
|
|
1996
|
6 |
Supplement 3 |
p. 70-
1 p.
|
artikel
|
| 164 |
Youth suicide in Victoria: A retrospective study
|
Burrows, G.D.
|
|
1996
|
6 |
Supplement 3 |
p. 89-
1 p.
|
artikel
|
Tijdschrift beschrijving